Brooks Laboratories Reports Record Sales Amid Challenges in Debtor Management
Brooks Laboratories reported its financial results for the quarter ending December 2024, showcasing a significant increase in net sales and operating profit, both reaching their highest levels in five quarters. However, the company faces challenges with a declining debtor turnover ratio, indicating issues in debt management.
Brooks Laboratories, a microcap company in the Pharmaceuticals & Drugs industry, recently announced its financial results for the quarter ending December 2024. The report, released on February 13, 2025, highlights notable developments in the company's financial performance.The net sales for the quarter reached Rs 38.45 crore, reflecting a significant growth rate of 96.7% compared to the average net sales of Rs 19.55 crore over the previous four quarters. This marks the highest quarterly sales figure for Brooks Laboratories in the last five quarters, indicating a positive near-term sales trend.
Additionally, the operating profit (PBDIT) also reached a peak of Rs 1.85 crore, the highest recorded in the last five quarters, further supporting the positive outlook for the company's operational performance.
However, the financial results also reveal challenges, particularly in the company's debtor management. The debtors turnover ratio has declined to 3.30 times, the lowest in the last five half-yearly periods, suggesting a slowdown in the pace at which Brooks Laboratories is settling its debts.
Overall, the evaluation changes reflect a complex picture for Brooks Laboratories as it navigates both opportunities and challenges in its financial landscape.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
